Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank W Pun

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 12, 2024
Utilizing AI for the Identification and Validation of Novel Therapeutic Targets and Repurposed Drugs for EndometriosisBonnie Hei Man Liu, Yuezhen Lin, Xi Long, et al.
Npj Aging|December 17, 2025
AI-aided identification of dual-purpose therapeutic targets PRPF19 and MAPK9 in hepatocellular carcinoma and cellular senescenceChristopher Ren, Geoffrey Ho Duen Leung, Qiuqiong Tang, et al.
Schizophrenia Research|December 31, 2011
Epigenetic regulation on GABRB2 isoforms expression: developmental variations and disruptions in psychotic disordersCunyou Zhao, Feng Wang, Frank W Pun, et al.
Nature Reviews. Drug Discovery|April 20, 2026
Target identification and assessment in the era of AIFrank W Pun, Dmitriy Podolskiy, Evgeny Izumchenko, et al.
Ageing Research Reviews|August 14, 2025
From clock to clock: Therapeutic target discovery for aging and age-related diseasesJianjiu Chen, Geoffrey Ho Duen Leung, Howell Leung, et al.
Biochemical Society Transactions|November 14, 2009
GABRB2 in schizophrenia and bipolar disorder: disease association, gene expression and clinical correlationsJianhuan Chen, Shui-Ying Tsang, Cun-You Zhao, et al.
Plos One|September 19, 2009
Alternative-splicing in the exon-10 region of GABA(A) receptor beta(2) subunit gene: relationships between novel isoforms and psychotic disordersCunyou Zhao, Zhiwen Xu, Feng Wang, et al.
Scientific Reports|April 12, 2026
Advancing target discovery through disease-specific integration of multi-modal target identification models and comprehensive benchmarking systemHowell Leung, Chengchen Duan, Wenhao Gou, et al.
Journal of Chemical Information and Modeling|February 26, 2024
PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker DiscoveryPetrina Kamya, Ivan V Ozerov, Frank W Pun, et al.
Journal of Medicinal Chemistry|November 12, 2025
Discovery and Biological Evaluation of Novel, Potent, and Orally Available CBLB InhibitorsFanye Meng, Zhongying Cao, Jinxin Liu, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 12, 2024
Utilizing AI for the Identification and Validation of Novel Therapeutic Targets and Repurposed Drugs for EndometriosisBonnie Hei Man Liu, Yuezhen Lin, Xi Long, et al.
Npj Aging|December 17, 2025
AI-aided identification of dual-purpose therapeutic targets PRPF19 and MAPK9 in hepatocellular carcinoma and cellular senescenceChristopher Ren, Geoffrey Ho Duen Leung, Qiuqiong Tang, et al.
Schizophrenia Research|December 31, 2011
Epigenetic regulation on GABRB2 isoforms expression: developmental variations and disruptions in psychotic disordersCunyou Zhao, Feng Wang, Frank W Pun, et al.
Nature Reviews. Drug Discovery|April 20, 2026
Target identification and assessment in the era of AIFrank W Pun, Dmitriy Podolskiy, Evgeny Izumchenko, et al.
Ageing Research Reviews|August 14, 2025
From clock to clock: Therapeutic target discovery for aging and age-related diseasesJianjiu Chen, Geoffrey Ho Duen Leung, Howell Leung, et al.
Biochemical Society Transactions|November 14, 2009
GABRB2 in schizophrenia and bipolar disorder: disease association, gene expression and clinical correlationsJianhuan Chen, Shui-Ying Tsang, Cun-You Zhao, et al.
Plos One|September 19, 2009
Alternative-splicing in the exon-10 region of GABA(A) receptor beta(2) subunit gene: relationships between novel isoforms and psychotic disordersCunyou Zhao, Zhiwen Xu, Feng Wang, et al.
Scientific Reports|April 12, 2026
Advancing target discovery through disease-specific integration of multi-modal target identification models and comprehensive benchmarking systemHowell Leung, Chengchen Duan, Wenhao Gou, et al.
Journal of Chemical Information and Modeling|February 26, 2024
PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker DiscoveryPetrina Kamya, Ivan V Ozerov, Frank W Pun, et al.
Journal of Medicinal Chemistry|November 12, 2025
Discovery and Biological Evaluation of Novel, Potent, and Orally Available CBLB InhibitorsFanye Meng, Zhongying Cao, Jinxin Liu, et al.
Pageof 5